Sign in
4

Changes in Ownership

Caribou Biosciences, Inc. Filed Acc 0001209191-21-060424

Chief Scientific Officer bought 114,860 shares at an average $1.92 ($220,757)

From the SEC's structured data for this filing

Trades in this filing

Kanner Steven · Chief Scientific Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-10-12 Purchase : show line 1 in the form +99,548 $1.81 $180,182 199,719 D
2021-10-12 Purchase : show line 2 in the form +698 $1.81 $1,263 200,417 D
2021-10-12 Purchase : show line 3 in the form +14,614 $2.69 $39,312 215,031 D
Open-market purchases · 114,860 sh · avg $1.92 · $220,757

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2021-10-12 Option exercise : show line 4 in the form Option to purchase Common Stock −99,548 71,840 D
2021-10-12 Option exercise : show line 5 in the form Option to purchase Common Stock −698 4,879 D
2021-10-12 Option exercise : show line 6 in the form Option to purchase Common Stock −14,614 132,134 D
Loading xslF345X03/doc4.xml…